FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 25, Issue 12, Pages 3983-3989
Publisher
Oxford University Press (OUP)
Online
2010-06-05
DOI
10.1093/ndt/gfq309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
- (2009) Dinanda J. de Jager JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
- (2009) Takashi Shimada et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
- (2009) Tamara Isakova et al. KIDNEY INTERNATIONAL
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disordered Mineral Metabolism in Hemodialysis Patients: An Analysis of Cumulative Effects in the Hemodialysis (HEMO) Study
- (2008) Ron Wald et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
- (2008) Francesca Tentori et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- FGF-23–Klotho signaling stimulates proliferation and prevents vitamin D–induced apoptosis
- (2008) Damian Medici et al. JOURNAL OF CELL BIOLOGY
- Phosphorus Binders and Survival on Hemodialysis
- (2008) T. Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oral active vitamin D is associated with improved survival in hemodialysis patients
- (2008) Manuel Naves-Díaz et al. KIDNEY INTERNATIONAL
- Does FGF23 toxicity influence the outcome of chronic kidney disease?
- (2008) M. S. Razzaque NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now